Web Resource
Government Resource

New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients.

United States Food and Drug Administration; FDA.

This announcement describes revised dosing recommendations designed to prevent overdosing immunocompromised pediatric patients.